NWBO
Price:
$0.19
Market Cap:
$312.23M
Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology firm that creates personalized immune-based treatments for various cancers, operating both within the United States and internationally. Their product pipeline relies on DCVax, a proprietary technology platform. This platform harnesses a patient's own activated dendritic cells to stimulate their immune system to combat cancerous cells. The company's leading therapeutic candidate, DCVax-L, has successfully completed Phase III clinical trials targeting Glioblastoma multiforme, an aggressive form of brain cancer. Additionally, Northwest Biotherapeutics is progressing DCVax-Direct through Phase I/II clinical studies, focusing on the treat...[Read more]
Industry
Biotechnology
IPO Date
2001-12-14
Stock Exchange
OTC
Ticker
NWBO
According to Northwest Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.33. This represents a change of -184.36% compared to the average of 7.50 of the last 4 quarters.
The mean historical PE Ratio of Northwest Biotherapeutics, Inc. over the last ten years is -3.64. The current -6.33 PE Ratio has changed 17.28% with respect to the historical average. Over the past ten years (40 quarters), NWBO's PE Ratio was at its highest in in the June 2019 quarter at 162.50. The PE Ratio was at its lowest in in the March 2021 quarter at -76.02.
Average
-3.64
Median
-3.02
Minimum
-12.27
Maximum
3.33
Discovering the peaks and valleys of Northwest Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 200.00%
Maximum Annual PE Ratio = 3.33
Minimum Annual Increase = -335.35%
Minimum Annual PE Ratio = -12.27
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -5.39 | 36.97% |
| 2024 | -3.94 | -67.92% |
| 2023 | -12.27 | 56.38% |
| 2022 | -7.84 | -335.35% |
| 2021 | 3.33 | -259.04% |
| 2020 | -2.10 | -60.08% |
| 2019 | -5.25 | 200.00% |
| 2018 | -1.75 | 126.04% |
| 2017 | -0.77 | 70.32% |
| 2016 | -0.45 | -78.98% |
The current PE Ratio of Northwest Biotherapeutics, Inc. (NWBO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.20
5-year avg
-5.22
10-year avg
-3.64
Northwest Biotherapeutics, Inc.’s PE Ratio is greater than Healios K.K. (-10.67), less than Hansa Biopharma AB (publ) (-4.11), greater than CytoDyn Inc. (-8.44), less than Cellectis S.A. (-4.55), less than Immutep Limited (-0.92), less than Clinuvel Pharmaceuticals Limited (15.85), less than PureTech Health plc (-3.78), greater than Avacta Group Plc (-7.84), less than Frontage Holdings Corporation (40.60), greater than MedinCell S.A. (-26.46),
| Company | PE Ratio | Market cap |
|---|---|---|
| -10.67 | $193.79M | |
| -4.11 | $245.80M | |
| -8.44 | $369.83M | |
| -4.55 | $251.93M | |
| -0.92 | $73.69M | |
| 15.85 | $371.02M | |
| -3.78 | $413.81M | |
| -7.84 | $468.40M | |
| 40.60 | $223.05M | |
| -26.46 | $1.23B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Northwest Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Northwest Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Northwest Biotherapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Northwest Biotherapeutics, Inc. (NWBO)?
What is the highest PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
What is the 3-year average PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
What is the 5-year average PE Ratio for Northwest Biotherapeutics, Inc. (NWBO)?
How does the current PE Ratio for Northwest Biotherapeutics, Inc. (NWBO) compare to its historical average?